Leflunomide and Revatio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Leflunomide (leflunomide) and Revatio (sildenafil citrate). Common drug interactions include sepsis among females and atrial tachycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Leflunomide and Revatio. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 82,105 Leflunomide users. Check the latest studies of Leflunomide.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 44,849 Revatio users. Check the latest studies of Revatio.



On Aug, 08, 2026

32 people who take Leflunomide and Revatio together, and have interactions are studied.

Leflunomide and Revatio drug interactions.

What are the common drug interactions of Leflunomide and Revatio, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Skin infection
  3. Skin injury
  4. Spinal column stenosis (narrowing of spinal column)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Tunnel vision (the loss of peripheral vision with retention of central vision)
  7. Headache (pain in head)
  8. Memory impairment
  9. Peripheral swelling
  10. Wrist fracture

male:

  1. Atrial tachycardia (rhythm disturbance that arises in the atria)
  2. Chest pain
  3. Spinal compression fracture (fracture due to spinal compression on bone)
  4. Anticonvulsant drug level increased
  5. Balance disorder
  6. Dizziness
  7. Fluid overload (too much fluid in the blood)
  8. Gait disturbance
  9. Lung infection
  10. Strabismus (a disorder in which the two eyes do not line up in the same direction)

What are the common drug interactions of Leflunomide and Revatio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Multiple allergies (allergy to multiple agents)

40-49:

  1. Anticonvulsant drug level increased
  2. Balance disorder
  3. Dizziness
  4. Gait disturbance
  5. Lung infection
  6. Pneumonia
  7. Strabismus (a disorder in which the two eyes do not line up in the same direction)
  8. Vision blurred
  9. Visual impairment
  10. Weight decreased

50-59:

  1. Weight increased
  2. Wrist fracture
  3. Dyspnoea (difficult or laboured respiration)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Alanine aminotransferase increased
  6. Anaemia (lack of blood)
  7. Aspartate aminotransferase increased
  8. Atrial tachycardia (rhythm disturbance that arises in the atria)
  9. Blood alkaline phosphatase increased
  10. Chest pain

60+:

  1. Fall
  2. Headache (pain in head)
  3. Dyspnoea (difficult or laboured respiration)
  4. Blood pressure diastolic decreased
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Device dislocation
  7. Diarrhoea
  8. Dyspepsia (indigestion)
  9. Fractured sacrum
  10. Hyperaemia (increase of blood flow to different tissues in the body)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 53.12%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 18.75%
  3. Pain: 6 people, 18.75%
  4. Hypoaesthesia (reduced sense of touch or sensation): 4 people, 12.50%
  5. Depression: 4 people, 12.50%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 12.50%
  7. Gastric Disorder (disease of stomach): 4 people, 12.50%
  8. High Blood Cholesterol: 4 people, 12.50%
  9. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 4 people, 12.50%
  10. Irritable Bowel Syndrome: 4 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Leflunomide and Revatio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Leflunomide and Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Leflunomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Revatio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on leflunomide and sildenafil citrate (the active ingredients of Leflunomide and Revatio, respectively), and Leflunomide and Revatio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: